ACE2 and COVID-19: There are several potential approaches to address ACE2‐mediated COVID‐19, such as spike protein‐based vaccine (rely on the fact that ACE2 is the COVID‐19 receptor), inhibition of transmembrane protease activity (essential for entry through interaction with ACE2 receptor), blocking ACE2 receptor, and delivering the soluble form of ACE2.